Vontobel Financial Products GmbH Share Price

Certificat

DE000VM505E0

Market Closed - Deutsche Boerse AG 19:06:23 03/07/2024 BST
106.2 EUR 0.00% Intraday chart for Vontobel Financial Products GmbH
Current month-0.26%
1 month+0.89%
Date Price Change
03/07/24 106.2 0.00%
02/07/24 106.2 +0.01%
01/07/24 106.1 -0.27%
28/06/24 106.4 +0.01%
27/06/24 106.4 +0.01%

Delayed Quote Deutsche Boerse AG

Last update July 03, 2024 at 07:06 pm

More quotes

Static data

Product typesonstige Zertifikate
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WKN VM505E
ISINDE000VM505E0
Date issued 29/11/2023
Strike 236.3 CHF
Maturity 28/02/2025 (240 Days)
Parity 0.24 : 1
Emission price 100
Emission volume N/A
Settlement Beides
Currency EUR

Technical Indicators

Highest since issue 106.5
Lowest since issue 97.09

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
246 CHF
Average target price
278.3 CHF
Spread / Average Target
+13.12%
Consensus